L Gu, C Peng, Q Liang, Q Huang, D Lv… - … and Targeted Therapy, 2024 - nature.com
The potential benefit of neoadjuvant toripalimab plus axitinib in cases with clear cell renal
cell carcinoma (ccRCC) and inferior vena cava tumor thrombus (IVC-TT) remains unclear …